Biography

Jeffrey S. Hochman is a partner in Willkie’s Corporate and Financial Services Department. Mr. Hochman specializes in mergers and acquisitions of both public and private companies, public offerings, private equity transactions and general corporate and securities law.  He regularly advises boards of directors and executives regarding corporate governance issues and other sensitive matters.

Over the past several years, Mr. Hochman has worked closely with a broad range of companies, including pharmaceutical, insurance and technology companies.  He advises issuers on ongoing SEC disclosure and other corporate matters, while also representing underwriters in connection with various securities offerings.  Mr. Hochman has also worked on “going private” transactions and special committee assignments, as well as other securities and M&A transactions. 

SELECTED PROFESSIONAL AND BUSINESS ACTIVITIES

Mr. Hochman is a member of the Business Law Section of the American Bar Association.  He has spoken on the Sarbanes-Oxley Act and corporate governance issues, MD&A, negotiating merger agreements and other corporate and securities issues for the Practising Law Institute. 

SELECTED SIGNIFICANT MATTERS

Recent significant transactions include representing:

The Sterling Group in its sale of DexKo Global Inc.
Teva Pharmaceutical Industries Ltd. in its series of three multi-tranche, multi-market offerings of senior notes aggregating $20.4 billion to finance its acquisition of Actavis Generics 
Teva Pharmaceutical in its $6.75 billion aggregate ADS and mandatorily convertible preferred stock offerings
Special Committee of the Board of Directors of WuXi PharmaTech Inc. in its $3.3 billion management-led leveraged buyout
HealthEquity, Inc. in connection with its $147 million IPO and various follow-on offerings 
 
BAR ADMISSIONS

Mr. Hochman is admitted to the Bar of the State of New York. 

EDUCATION

Mr. Hochman received a JD from Columbia University School of Law in 1991, where he was a Stone Scholar.  He received a BS from Columbia University School of Engineering in Chemical Engineering and a BA (magna cum laude in Chemistry) from Yeshiva University in 1988.

Associated Items

1 item
Date
Program or Publication
Format